Chronic Myeloproliferative Disorders Completed Phase Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00290641Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerTreatment
NCT00068523Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic MalignanciesTreatment
NCT00296023Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerTreatment